Indices: Stock market update: Nifty Pharma index falls 0.52%
The Nifty Pharma index closed 0.52 per cent down at 19216.35.
Stay updated with breaking news from Biocon Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The Nifty Pharma index closed 0.52 per cent down at 19216.35.
The US Food and Drug Administration (USFDA) has approved the company's first-to-file application for Yesafili, a vascular endothelial growth factor inhibitor used to treat several different types of ophthalmology conditions, the company said in a statement.
The Nifty Pharma index was trading 0.11 per cent down at 19086.2.
Biocon Biologics secures FDA approval for Yesafili, an interchangeable biosimilar to Eylea, for ophthalmological conditions. Launch in Canada set.
This open high low scanner or OHL Scanner uses the popular open high low same trading strategy to find profitable stocks from NSE.